anti-CD19 CAR NK cells (KN5501) Clinical Trials
2 recruitingDrug
Early Phase 12
Showing 1–2 of 2 trials
Recruiting
Early Phase 1
An Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Primary Immune Thrombocytopenia
Thrombocytopenia Alloimmune
Changzhou No.2 People's Hospital9 enrolled1 locationNCT06337474
Recruiting
Early Phase 1
An Exploratory Clinical Study of Anti-CD19 CAR NK Cells in the Treatment of Systemic Lupus Erythematosus
Systemic Lupus Erythematosus (SLE)
Changhai Hospital36 enrolled1 locationNCT06010472